PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $175,000 | -14.2% | 18,000 | -10.0% | 0.42% | -5.4% |
| Q2 2018 | $204,000 | -21.5% | 20,000 | 0.0% | 0.44% | -13.3% |
| Q1 2018 | $260,000 | -63.7% | 20,000 | -50.0% | 0.51% | -17.6% |
| Q4 2017 | $716,000 | -28.7% | 40,000 | 0.0% | 0.62% | -31.3% |
| Q3 2017 | $1,004,000 | +4.1% | 40,000 | 0.0% | 0.90% | +2.0% |
| Q2 2017 | $964,000 | -37.4% | 40,000 | -50.0% | 0.88% | -22.7% |
| Q1 2017 | $1,540,000 | +25.0% | 80,000 | 0.0% | 1.14% | +16.5% |
| Q4 2016 | $1,232,000 | +18.3% | 80,000 | 0.0% | 0.98% | +68.0% |
| Q3 2016 | $1,041,000 | +98.7% | 80,000 | +112.4% | 0.58% | +15.4% |
| Q2 2016 | $524,000 | -23.3% | 37,665 | -16.3% | 0.51% | -4.2% |
| Q1 2016 | $683,000 | -40.0% | 45,000 | -25.0% | 0.53% | -29.8% |
| Q4 2015 | $1,138,000 | – | 60,000 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |